GlassScriptPrepare for your visit
Chidera C Ejiogu
Obstetrics & Gynecology · Houston, TX · NPI 1124377486
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$576.12
in general payments reported to CMS, 2019-2025 · $98.45 in 2025
The $98.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Exeltis, USA INC. $140.14
- Medtronic, INC. $44.75
- Agile Therapeutics, INC. $39.82
- Abbvie INC. $39.04
- Organon LLC $35.88
- Vertical Pharmaceuticals, LLC $34.67
Drugs and devices associated with these payments
Twirla Nexplanon Phexxi Solosec Phexx Myfembree Femlyv Veozah Abrysvo Prevnar 20 Penbraya
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Chidera Ejiogu listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1377705/chidera-c-ejiogu